True about Alpha1 antitrypsin deficiency is?
The correct answer is probably related to the main features of the condition. Let's think about the options. Common facts include that it's an autosomal recessive disorder, associated with emphysema, especially in smokers, and causes liver disease like cirrhosis in adults and neonatal hepatitis in infants. Also, the deficiency is due to reduced production of the protein, not increased enzyme activity.
Now, looking at possible distractors. If an option says it's caused by increased elastase activity, that's wrong because the problem is lack of inhibition. If an option mentions it's more common in smokers, that's true but a bit too specific. Another might confuse it with alpha1 antichymotrypsin. Also, the main organ affected in the lungs and liver. So the correct answer would be something like "It is an autosomal recessive disorder leading to emphysema and liver disease."
Now, the user didn't provide the actual options, so I need to make sure the explanation covers the core concepts. The core concept is the role of AAT in inhibiting proteases, leading to lung and liver damage when deficient. The correct answer would highlight the autosomal recessive inheritance and the diseases it causes. The incorrect options would be about other causes, different inheritance patterns, or incorrect organs involved. The clinical pearl is that AAT deficiency is a known cause of early-onset emphysema and liver disease, and testing is indicated in such cases.
**Core Concept**
Alpha1 antitrypsin (AAT) deficiency is an autosomal recessive disorder caused by mutations in the SERPINA1 gene, leading to reduced production of the protease inhibitor AAT. This results in uncontrolled neutrophil elastase activity, causing lung tissue destruction (emphysema) and hepatic damage (cirrhosis, hepatocellular carcinoma).
**Why the Correct Answer is Right**
The correct statement would highlight the autosomal recessive inheritance pattern and the association with panacinar emphysema, particularly in smokers. AAT deficiency is the most common genetic cause of liver disease in infants and adults, with PiZZ genotype being the most severe variant. The lack of functional AAT allows excessive elastase-mediated degradation of alveolar walls, accelerating lung damage.
**Why Each Wrong Option is Incorrect**
**Option A:** "Caused by increased neutrophil elastase production" β Incorrect. The deficiency reduces AAT, not elastase; the imbalance is due to *lack of inhibition*, not excess enzyme.
**Option B:** "X-linked recessive disorder" β Incorrect. SERPINA1 mutations are inherited in an autosomal recessive pattern.
**Option C:** "Primarily affects the kidneys" β Incorrect. The primary targets are the liver and lungs, not the kidneys.
**Option D:** "Treated with corticosteroids" β Incorrect. AAT replacement therapy is the mainstay; corticosteroids are ineffective for the underlying deficiency.
**Clinical Pearl /